AstraZeneca to invest $2 billion in Maryland manufacturing expansion
The multibillion-dollar Maryland expansion is part of AstraZeneca’s sweeping $50 billion global investment plan
The multibillion-dollar Maryland expansion is part of AstraZeneca’s sweeping $50 billion global investment plan
This is the first and only subcutaneous immune checkpoint inhibitor available in Europe
Exemplifies commitment of Merck to energy efficiency and sustainable practices in high-performance computing by featuring advanced water-cooling systems and a hybrid cloud infrastructure
The formulation is backed by over 80 clinical trials and 200 scientific publications
Innovent plans to soon submit a new drug application (NDA) to China’s National Medical Products Administration
Glucagon-Like Peptide-1 is a natural hormone that regulates blood sugar, controls appetite, and slows digestion
The initiative aims to connect startups and tech companies with its business units,
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
Subscribe To Our Newsletter & Stay Updated